# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Howard Hughes (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML006-SYN-TD
- Date: 1947-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anselm Garrity-Moyo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Establishing primary care ten months after a plane crash: contamination fears with washing and avoidance, chronic pain on long-term codeine, an opioid review, hearing, weight, kidney health and safety. **S**

## Historical basis

- Howard Robard Hughes Jr. was born in Houston, Texas, on December 24, 1905, the only child of an oilman whose drill bit became the foundation of the family fortune. **D**
- After an unexplained paralysis in 1919, as a boy, he developed what a state historical handbook calls a lifetime phobic regard for his health; a psychologist who studied his life after his death concluded that his fear for his health began in childhood. **D**
- He suffered a nervous breakdown in 1944. **D**
- On July 7, 1946, on the first flight of the XF-11 reconnaissance plane, he crashed into houses in Beverly Hills and was critically injured, with a crushed chest, a collapsed lung, multiple broken bones and second- and third-degree burns; he nearly died. **D**
- Drugs for pain were first given to him after the 1946 crash; the crash left him with lingering pain and an addiction to codeine, the beginning of a lifelong dependence on painkillers. **D**
- His fear of germs grew throughout his life, with efforts to protect himself from contamination from outside; a news magazine linked his celebrated fear of germs in part to the 1946 crash, which injured his lungs and left him susceptible to bronchial infection. **D**

9 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He wants to get back to full days of work without hours of washing and checking, and without other people seeing his rituals. **S**
- He is afraid that without codeine the pain from the crash will stop him working. **S**
- He wants his privacy protected and nothing about his care known outside the clinic. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a day **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staff **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1919: Paralysis as a boy for which no cause was found, after which he developed a lasting fear for his health **D** (CLM-0003)
- 1944: A nervous breakdown, recorded without detail **D** (CLM-0004)
- July 7, 1946: Critical injuries in a plane crash: crushed chest, collapsed lung, multiple fractures and burns; pain and codeine since **D** (CLM-0005, CLM-0006)

## Procedures and immunizations

- No procedures before this visit. **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

White blood cells: 6.4 10*3/uL; Hemoglobin: 14.1 g/dL; MCV: 91 fL; Platelets: 248 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.94 mg/dL; eGFR (CKD-EPI 1942): 104 mL/min/1.73 m²; Glucose: 84 mg/dL; AST: 31 U/L; ALT: 38 U/L; Albumin: 3.7 g/dL; TSH: 1.6 mIU/L; Urine albumin-to-creatinine ratio: 8 mg/g{creat}; PHQ-9: 9; GAD-7: 12; DAST-10: 5; AUDIT-C: 1; PEG pain scale: 6.7. All results are synthetic.

BP 122/78 mmHg; pulse 92 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 72 kg; BMI 19.7 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, intense and courteous; declines to shake hands and keeps his gloves on until he has washed; speech normal in rate, a little loud; mood anxious; contamination obsessions with washing, cleaning and avoidance compulsions, Y-BOCS 28 (obsessions 14, compulsions 14); he says the fears are probably excessive (good or fair insight); no hallucinations or delusions; no thoughts of suicide or of harming anyone. Functional status: Independent in all activities; spends about four hours a day on washing and checking; avoids meetings and handshakes; reaches overhead with the left arm only with pain. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: absent; intent: absent; plan: absent; access reviewed: yes. Disposition: Outpatient care with weekly visits at first. Risk factors reviewed without detail: a breakdown in earlier years, opioid use disorder, chronic pain, severe OCD, isolation and anxiety. No current thoughts of suicide. Opioids are dangerous in overdose, so means safety is part of the plan: naloxone nasal spray at home with his staff taught to use it, unused codeine tablets taken to a pharmacy take-back, and buprenorphine dispensed one week at a time at first. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluation; status draft. **S**
2. Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine planned; status draft. **S**
3. Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7; status draft. **S**
4. Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluation; status draft. **S**
5. Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fears; status draft. **S**

## Plan

- Psychiatry consultation to confirm the diagnosis, advise on an SSRI at OCD doses with buprenorphine, plan exposure and response prevention, and advise on how his staff can stop carrying out rituals for him. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch (March 2013): Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (Koran LM, Simpson HB), as reported by Psychiatric News (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Opioid review under the CDC 1943 guideline: benefits and harms reviewed with him, a prescription drug monitoring program check before every controlled-substance prescription, urine drug testing with consent and explained as part of care, one prescriber and one pharmacy, a nonjudgmental DSM-5-TR assessment for opioid use disorder, and no abrupt stop of codeine. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022); Prescription Drug Monitoring Programs (PDMPs) (2026) **S**
- Buprenorphine with naloxone for opioid use disorder and pain: induction in the clinic at one week after about 20 hours without codeine, then 8 mg twice daily, dispensed weekly at first; naloxone nasal spray at home; no benzodiazepines; leftover codeine to a pharmacy take-back. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020) **S**
- Pain after major trauma: scheduled acetaminophen up to 3,000 mg a day, physical therapy for the chest wall, left shoulder and low back, graded activity, sleep, and pain coping skills woven into his therapy; no NSAID long term. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022) **S**
- Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety for opioids, and safety review at every visit. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Hearing: audiometry, then hearing aids and a remote microphone if hearing loss is confirmed; hearing protection when flying and in the factory. Guideline: Hearing loss in adults: assessment and management (NG98) (2018) **S**
- Kidney health: creatinine, eGFR and urine albumin at baseline and a metabolic panel at follow-up while on scheduled acetaminophen and any new medicine; acetaminophen kept at or below 3,000 mg a day; no long-term NSAID. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022) **S**
- Privacy: care documented in the clinic record only; letters about his health go only to people he names. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007) **S**

## Guideline basis

- Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007), American Psychiatric Association (American Journal of Psychiatry 2007;164(7 Suppl):5-53)
- Guideline Watch (March 2013): Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (Koran LM, Simpson HB), as reported by Psychiatric News (2013), American Psychiatric Association
- Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005), National Institute for Health and Care Excellence
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports 2022;71(3):1-95)
- The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020), American Society of Addiction Medicine (Journal of Addiction Medicine)
- Prescription Drug Monitoring Programs (PDMPs) (2026), Centers for Disease Control and Prevention
- Hearing loss in adults: assessment and management (NG98) (2018), National Institute for Health and Care Excellence
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
